Lisa Peraza
Vermogen: 107 550 $ op 30-06-2026
Vermogen: 107 550 $ op 30-06-2026
Lisa Peraza is Vice President-Finance at Connect Biopharma Holdings Ltd. since 2024.
Formerly, Ms. Peraza was Chief Accounting Officer & Vice President at Heron Therapeutics, Inc. from 2020 to 2024 and Executive Director & Controller at Ardea Biosciences, Inc. from 2008 to 2014.
Education includes undergraduate studies at the University of California, Santa Barbara.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-03-2026 | 45.189 ( 0,08% ) | 107 550 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Financieel Directeur/CFO | 13-09-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| HERON THERAPEUTICS, INC. | Hoofd Administratief Officier | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Directeur/Bestuurslid | 01-03-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau